Genenta Science landed on Nasdaq on Wednesday, December 15. The scaleup active in research for the treatment of cancer is the first Italian company to list on the American technology list. Genenta Science was founded in 2014, founded by Pierluigi Paracchi (CEO) with Luigi Naldini, director of the Division of Regenerative Medicine, Stem Cells and Ge...